The effectiveness of calcium hydroxylapatite-based Implant in eliminating increased sensitivity of teeth

Abstract

BACKGROUND: Dental hypersensitivity affects up to 57% of the world’s population. In Russia, high demand for treating hyperesthesia was found among patients aged 30–59 years. Despite the large number of studies conducted, understanding of the etiology and proposed treatment methods to eliminate increased sensitivity of teeth, there is still no effective drug to treat this pathology. Current methods do not ensure long-term elimination of hypersensitivity, which substantiates the need to develop new treatment methods. AIM: To determine the effectiveness of the Radiesse implant (Merz North America, USA) in patients with dental hyperesthesia. MATERIALS AND METHODS: Eighty-six patients aged 35–44 years — men and women with dental hyperesthesia — were examined. The condition of periodontal tissues of teeth with hypersensitivity was assessed by clinical examination methods, and an objective assessment of dental hypersensitivity (tactile impact — TV) was carried out using an electromagnetic device Yeaple Probe (XininX Research Inc., USA). RESULTS: Dental hypersensitivity after a single injection of the Radiesse implant steadily decreases compared to its initial values. CONCLUSIONS: Dental hypersensitivity after a single injection of the Radiesse implant steadily decreases compared to its initial values (p 0.05). Effective reduction of dental hypersensitivity when using Radiesse (Merz North America, USA) lasts for more than 6 months in contrast to the effect of standard treatments.